Annexon Inc (ANNX)
4.70
-0.18
(-3.69%)
USD |
NASDAQ |
May 23, 16:00
4.70
0.00 (0.00%)
After-Hours: 17:19
Annexon Cash from Financing (Quarterly): 32.41M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 32.41M |
| December 31, 2023 | 117.60M |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.345M |
| March 31, 2023 | 17.58M |
| December 31, 2022 | 0.108M |
| September 30, 2022 | 122.67M |
| June 30, 2022 | 0.113M |
| March 31, 2022 | 0.019M |
| December 31, 2021 | 0.948M |
| September 30, 2021 | -0.073M |
| Date | Value |
|---|---|
| June 30, 2021 | 0.652M |
| March 31, 2021 | 0.268M |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 259.78M |
| June 30, 2020 | 101.67M |
| March 31, 2020 | -0.571M |
| December 31, 2019 | -0.846M |
| September 30, 2019 | 29.24M |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.003M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.846M
Minimum
Dec 2019
259.78M
Maximum
Sep 2020
34.10M
Average
0.3065M
Median
Cash from Financing (Quarterly) Benchmarks
| Trxade Health Inc | 1.335M |
| P3 Health Partners Inc | 11.40M |
| Arrowhead Pharmaceuticals Inc | 430.78M |
| Insmed Inc | 3.022M |
| Heron Therapeutics Inc | 0.011M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -28.27M |
| Cash from Investing (Quarterly) | -77.30M |
| Free Cash Flow | -116.42M |
| Free Cash Flow Per Share (Quarterly) | -0.2304 |
| Free Cash Flow Yield | -28.19% |